a r t i c l e s
Scaffold proteins orchestrate the formation and activity of multiprotein complexes and thereby control the flow of cellular information 1 . These proteins typically combine compact folded domains with large intrinsically disordered segments, which mediate highly specific but low-affinity interactions with multiple binding partners [2] [3] [4] [5] [6] . Misregulation of these signaling hubs is frequent in cancer, as exemplified by the large number of germline and somatic mutations in tumor-suppressor scaffolds, such as BRCA1, APC and Axin [6] [7] [8] [9] . A major fraction of these mutations comprises single point mutations with poorly understood functional implications. Basic insight into these mutants' molecular modes of action is of fundamental importance to define common principles by which mutagenic events drive carcinogenesis, to distinguish driver from passenger mutations and to provide prognostic information and guide therapeutic decisions.
Here we set out to identify driver mutations in the AXIN1 gene product, Axin, a critical tumor suppressor of Wnt signaling, and to uncover the mechanism by which these mutations cause oncogenesis. The primary role of Axin (Fig. 1a) is to scaffold a multiprotein destruction complex, which drives the phosphorylation and subsequent proteolysis of the transcriptional regulator β-catenin [10] [11] [12] [13] . In healthy cells, Wnt-mediated signals inhibit destruction-complex activity toward β-catenin, thus leading to β-catenin accumulation, nuclear entry and transcriptional activation of target genes involved in tissue self-renewal and growth [14] [15] [16] . Accordingly, aberrant activation of β-catenin due to mutations in destruction-complex components is frequently linked to the development of human cancer 16 . Restoration of normal Wnt-pathway regulation at late cancer stages can revert colorectal cancer cells into functioning normal cells, thus validating the Wnt pathway as an effective therapeutic target 17 .
Axin mutations are associated with a diverse set of tumors including hepatocellular, colorectal and endometrial carcinoma, melanoma and stomach adenocarcinoma (http://www.cbioportal.org/). Strikingly, the mutational spectrum in Axin shows a higher prevalence of missense mutations than deletions and truncations, and missense mutations are frequently accompanied by a gain in copy number and mRNA overexpression, thus suggesting a selective advantage of point-mutant protein expression in tumor development (http://cancer.sanger.ac.uk/ cosmic/gene/overview?ln=AXIN1). However, how the poorly classified class of Axin point mutants may contribute to tumorigenesis remains unknown.
Using a multiscale approach, including structural studies and wholeanimal assays, we uncovered a molecular mechanism by which missense mutations convert signaling hubs into protumorigenic proteins. We show that tumor growth-promoting cancer mutations in Axin destroy the conserved core of the N-terminal Axin RGS domain. The destabilized protein gains new properties by forming soluble nanometerscale aggregates of at least 4 or 5 molecules. Nonaggregating, natively disordered regions of Axin protrude from the oligomer as molecular tentacles that aberrantly engage key regulators. As a consequence, the Axin signaling network is rewired to allow activation of β-cateninmediated transcription. Importantly, blocking aggregation is sufficient to rescue tumor-suppressor activity of the mutant protein in vivo, whereas refolding of the damaged domain is not required. We propose that conformational conversion into nonamyloid, single-domain nanoaggregates constitutes a general gain-of-function mechanism for cancer mutations that destabilize signaling scaffolds.
RESULTS

Axin cancer point mutants fail to suppress Wnt signaling
Axin comprises an N-terminal RGS domain and a C-terminal oligomerizing DIX domain, both of which are connected by a natively disordered central region 4, 18, 19 (Fig. 1a) . The RGS domain, which mediates the interaction of Axin with the tumor suppressor APC, is affected by several cancer mutations 8, 18 . To assess how alterations in the RGS domain contribute to tumor growth, we analyzed a set of six point mutants in conserved RGS residues identified in human cancers [20] [21] [22] [23] (Fig. 1b and  Supplementary Fig. 1a ). We expressed these Axin variants in HEK293T cells and compared their activity in a β-catenin-dependent luciferase reporter assay (Fig. 1c,d ). We expected expression of functional Axin to suppress both background and Wnt-induced signaling. Indeed, we observed suppression of signaling for wild-type (WT) Axin and two mutants (Axin T122A and Axin S215L). In contrast, a subset of mutants markedly failed to inhibit β-catenin-mediated transcription. This was particularly striking for both Axin L101P and Axin L106R, which triggered strong signaling even in the absence of exogenous Wnt (Fig. 1c) . Therefore, these RGS variants, through an unknown molecular mechanism, are likely to interfere with β-catenin degradation.
Cancer mutations destabilize the Axin RGS domain
To elucidate the mechanism underlying the effects of the RGS variants, we mapped the mutants onto the structure of the RGS domain. Remarkably, none of the six cancer-associated mutations mapped to the conserved APC-binding groove (Fig. 1e) . The two mutations with the strongest effects occurred at buried residues, which are unable to directly interact with any potential Axin-binding partners: RGS L106R, which affects the architecture of the hydrophobic core, and RGS L101P, which alters the polypeptide backbone. We therefore asked whether tumorigenic RGS mutations might impair Axin function through long-range allosteric effects. Fluorescence-based thermal denaturation showed that RGS WT, RGS T122A and RGS S215L unfolded at similar temperatures (53-55 °C), thus indicating their structural integrity (Fig. 1f) . Strikingly, the functionally defective RGS R103M, RGS K203M and RGS L101P were substantially less stable (unfolding at 44-48 °C), and RGS L106R was even more destabilized (unfolding at 27 °C). Unfolding of all Axin RGS variants was accompanied by a loss of helical structure, as measured by circular dichroism spectroscopy (Supplementary Fig. 1b) . The highly destabilized RGS L106R mutant entirely lost α-helical propensity far below physiological temperature. Overall, the extent of destabilization significantly correlated with an inability to suppress β-catenin-mediated transcription ( Fig. 1g ; r = −0.97 and P = 0.0003). We conclude that the failure of cancer mutants to suppress β-catenin signaling is tightly coupled to the loss of RGS structural stability. 
RGS destabilization endows Axin with tumorigenic properties
We then investigated whether conventional loss of function of Axin might be responsible for the induction of β-catenin-mediated transcription, by using human HEK293T cells. Short interfering RNA (siRNA)-mediated depletion of Axin to 10% of WT levels did not induce substantial basal β-catenin-mediated transcription but instead enhanced cellular responses to Wnt (Fig. 2a,b) , as shown previously 24 . Hence, the mechanism by which Axin RGS mutants drive β-catenin activation in these cells appears to be not merely due to a reduction in the functional pool of Axin. Binding of RGS L101P and RGS L106R to APC was strongly impaired, consistently with these mutants' loss of structural integrity (Fig. 2c) . In contrast to the concentration-dependent induction of β-catenin-mediated transcription by the Axin L106R cancer mutant, an RGS-deleted variant of Axin (Axin ∆RGS) failed to induce substantial β-catenin activation over a range of tested protein concentrations (Fig. 2d,e) . Thus, Axin ∆RGS largely retained tumor-suppressor activity, in line with previous reports 25, 26 . In conclusion, it is not the loss of RGS function but the acquired destabilization that endows the Axin cancer mutants with new tumorigenic properties.
Unstable RGS forms nanoaggregates with disordered tentacles
To gain molecular insight into the structural defects of the Axin RGS mutants, we analyzed RGS-domain fragments of the most potent cancer variant, L106R, by NMR spectroscopy (Fig. 3) . We acquired 2D HSQC spectra of 15 N-labeled RGS WT (Fig. 3b) and RGS L106R mutant proteins ( Fig. 3c and Supplementary Fig. 1c ). Such spectra provided a fingerprint of the backbone of the folded protein, thus allowing us to monitor disturbances in the native structure at the level of individual residues. NMR spectra of RGS WT showed a spread signal pattern typical for a folded protein. In spectra of destabilized RGS L106R, npg a r t i c l e s signals corresponding to the natively disordered N-and C-terminal extensions were still present (N2-Y70 and S215-V220; Fig. 3c and Supplementary Fig. 1c ). However, we observed a dramatic loss of NMR signals corresponding to residues in the folded region of the protein, including the signals of both tryptophan side chains, which were clearly visible in the spectra of the WT at approximately 9 p.p.m. This result is consistent with destruction of the hydrophobic core.
Consequently, we applied small-angle X-ray scattering (SAXS) to analyze whether the unfolded nature might lead to aberrant oligomerization of the mutant protein. SAXS is a solution scattering method that determines shape parameters, such as the maximal extension of a complex (maximum diameter) and the average distance of the atoms from the gravity center of the complex (radius of gyration (R g )). RGS WT comprised a monomeric globular domain with an average R g of 2.3 nm and a maximum diameter (D max ) of 9 nm ( Fig. 3d ; apparent molecular ratio 26 kDa). In contrast, the dimensions of RGS L106R were clearly enlarged (R g of 7.2 nm; D max of 19 nm), thus indicating the formation of nanometer-scale aggregates of at least 4 or5 molecules (Fig. 3d) . Zero-angle intensity (I(0)) analysis revealed an apparent molecular ratio of RGS nanoaggregates of 120 kDa over a wide concentration range (20-80 µM). The formation of such nanoaggregates is in agreement with the observed loss of NMR signals in the hydrophobic core, because increased particle size strongly reduces NMR signal intensity, owing to slower tumbling 27 . The disordered N and C termini still remained visible in the NMR spectra, thus indicating that they remained dynamic (Fig. 3c) . Hence, these termini are not part of the oligomeric core but instead protrude and remain solvent exposed. We conclude that mutation-induced loss of RGS structure leads to the formation of nonamyloid, soluble nanoaggregates that still expose disordered regions of Axin such that they can engage with binding partners.
RGS aggregation interferes with Axin self-polymerization
We next analyzed whether RGS L106R self-association might interfere with Axin-complex assembly in the cell. Overexpressed Axin typically forms highly dynamic cytoplasmic puncta, in a process mediated by polymerization of its C-terminal DIX domain 19, 28 (Figs. 1a and 4a) . Axin L106R failed to form puncta, displaying a diffuse cytosolic localization. In a subset of cells, the protein partially accumulated in perinuclear structures reminiscent of aggresomes, in which misfolded proteins typically accumulate 29 ( Fig. 4a and Supplementary Fig. 2a-c) . These structures formed in a concentration-dependent manner ( Supplementary Fig. 2a ) and localized to the microtubule-organizing center (Supplementary Fig. 2b ) but did not recruit HDAC6 or vimentin, two commonly used markers for aggresomes 29, 30 ( Supplementary  Fig. 2c ). Of note, even in cells carrying aggresome-like structures, the majority (76%) of the mutant Axin protein resided in the diffuse cytosolic fraction, as quantified by fluorescence intensity. 
npg a r t i c l e s
This subcellular localization pattern of Axin L106R was strikingly distinct from that of Axin ∆RGS, which formed puncta indistinguishable from those of Axin WT (Fig. 4a) . Thus, the conformational conversion of the RGS domain rather than its loss altered the mode of Axin-complex assembly. To characterize the aggregates of mutant Axin in cells, we assessed their SDS solubility. Axin L106R displayed high solubility in SDS-containing buffers, similarly to the WT protein ( Supplementary Fig. 2d ), thus indicating that it does not form amyloid-type aggregates in cells. After coexpression of increasing amounts of Axin WT, Axin L106R localization shifted from the diffuse cytosolic pool and aggresome-like structures and colocalized with Axin WT in puncta (Fig. 4b) . These findings suggest that mutation-induced aggregation of the N-terminal RGS domain disables DIX-dependent polymerization of the Axin C terminus. An excess of WT Axin prevents the mutant protein from making aberrant RGS-RGS contacts, thus allowing the mutant protein to be incorporated in Axin WT multimerized complexes, probably through DIX domain-mediated interactions 19 . Concordantly with these observations, increasing doses of Axin WT suppressed the Axin L106R-mediated induction of β-catenin-mediated transcription (Supplementary Fig. 3 ). Importantly, pathway suppression occurred even in conditions in which mutant Axin was in excess over WT and accumulated in aggresomes ( Fig. 4b and Supplementary Fig. 3 ), thus suggesting that aggresome formation itself is not a dominant cause of pathway activation.
Preventing RGS aggregation restores Axin function in vitro
We then asked whether we could revert the gain-of-function phenotype by suppressing Axin aggregation. We used the algorithm TANGO to predict aggregation propensity in the Axin protein sequence 31 (Fig. 5a) . Strikingly, human Axin RGS carries only one prominent aggregationprone segment (D116-F124), which is probably responsible for aggregation of this protein. This segment is buried in the WT protein but is potentially accessible in mutants. We therefore introduced additional F119R or W118R F119R mutations in the aggregationprone segment of Axin L106R. These mutations were unable to restore stability (Supplementary Fig. 4a ) but were predicted to specifically suppress aggregation (Fig. 5a) . Remarkably, RGS L106R F119R partially restored monomerization in vitro, as shown by size-exclusion chromatography (SEC) and analytical ultracentrifugation (AUC) (Fig. 4c,d ). This result indicates that Axin RGS nanoaggregation is mediated by the segment D116-F124. For clarity, we defined this segment, the aggregon, as an experimentally verified stretch responsible for aggregation. Moreover, full-length Axin L106R F119R or Axin L106R W118R F119R also regained the ability to form cytosolic puncta in cells (Fig. 4a) and to prevent excess Wnt signaling ( Fig. 4e and Supplementary Fig. 4b-d) . Accordingly, suppression of aggregation by F119R was sufficient to revert the Axin L106R phenotype, despite not restoring the RGS fold (Supplementary Fig. 4a) . Thus, the nanoaggregates are the actual oncogenic species.
Mutation-induced aggregation rewires the Axin interactome
To gain understanding of why nanoscale aggregation of Axin derails Wnt signaling, we analyzed the interactomes of Axin WT and mutant proteins in human cells (Fig. 4f and Supplementary Table 1) . The destabilizing L106R mutant led to reduced binding of 34 of 115 partners of Axin WT and a gain of 196 new contacts, thus indicating a substantial rewiring of the interactome. However, introduction of the aggregon suppressor mutation considerably restored the Axin interactome (16 partners reconnected and 43 trapped partners released; Fig. 4f) .
STRING 32 analysis of Axin-interacting proteins that co-regulate cellular processes confirmed that Axin WT is central to the formation of a protein network involved in the regulation of β-catenin turnover and interacts with a regulatory phosphatase complex ( Supplementary  Fig. 5a ). Comparison of interactomes revealed that a number of known Wnt-pathway components (GSK3β, CK1, β-catenin, Dvl2 and Dvl3) remained bound to all Axin variants, whereas others progressively lost binding to Axin ∆RGS (APC and FAM123B) and Axin L106R (APC, FAM123B, TNKS and TNKS2) ( Supplementary  Fig. 5b,c) . Moreover, a third cluster of Axin-binding proteins comprised the eight subunits of the Gid complex, a large highly conserved E3 ubiquitin ligase complex involved in the regulation of gluconeogenesis in yeast 33, 34 . Of note, interaction with Gid-complex subunits was selectively lost for Axin L106R, whereas the aggregon suppressor mutation restored binding (Supplementary Fig. 5c,d ), thus revealing a potential role for altered regulation of glucose metabolism by Axin cancer mutants.
Our analysis predicted the large number of newly identified interactions of the Axin L106R cancer mutant to function in a diverse set a r t i c l e s of cellular processes, including mitosis, DNA-damage repair, protein trafficking and protein turnover (Supplementary Fig. 5e ). A protein cluster comprising seven components of the 26S proteasome was found to selectively bind the aggregation-prone Axin L106R mutant but not to interact with the Axin L106R F119R aggregon suppressor mutant (Supplementary Fig. 5e ). Thus, trapping of these proteasomal subunits by Axin L106R requires the aggregated state of Axin.
We conclude that the Axin interactome is substantially rewired by mutation-induced nanoaggregation, whereas loss of the RGS domain displays relatively mild effects. Thus, selective aggregation-dependent alterations in the Axin network are a likely cause of aberrant Wntsignaling activation and a potential growth advantage driven by destabilizing Axin mutations.
Axin RGS cancer mutants induce tumor-like growth in vivo
To assess the in vivo relevance of Axin aggregates, we used Drosophila. Drosophila wing imaginal discs provide an established model system to study the physiological activity of various tumor-suppressor genes. Moreover, Drosophila Wnt-cascade components show a high degree of conservation with the human system (30% identity and 67% similarity for Axin RGS) (Fig. 5c) . We used a recently established protocol for homologous recombination 35 to delete the first three exons of the Axin gene and to replace this region with a cassette including an attP recombination site (Supplementary Fig. 6a,b) . We then knocked in cDNAs expressing Drosophila Axin (dAxin) cancer variants in the endogenous Axn locus (Figs. 5c and 6a) . As shown previously, clonal deletion of endogenous Axn in the posterior compartment of wing imaginal discs overgrew at the expense of surrounding WT tissue 36 ( Fig. 6b and Supplementary Fig. 6c ). This phenotype resembles tissue colonization by precancerous cells. Deletion clones exhibited a round shape and a smooth edge (Fig. 6b) . When we knocked in WT Axn in the endogenous locus, mutant clones reverted to their normal jagged and elongated shape and no longer overgrew, as expected ( Fig. 6c and Supplementary Fig. 6c) .
Next, we generated clones expressing dAxin V72R, the equivalent of human Axin L106R (Fig. 5c) . At the standard temperature of 25 °C, these clones appeared normal in the pouch but had aberrantly smooth edges in the prospective notum and hinge (Fig. 6e) , thus indicating partial loss of function. Because Axin RGS L106R is thermolabile, we analyzed clone behavior at various temperatures. At 29 °C, dAxin V72R clones overgrew at the expense of surrounding WT tissue and displayed smooth edges in all regions ( Fig. 6e and Supplementary  Fig. 6c ). Moreover, we detected ectopic expression of senseless (official symbol sens) and Distal-less (Dll) in dAxin V72R clones, which indicated excess Wingless signaling activity (Supplementary Fig. 6d ). Of note, heterozygous tissue in the anterior compartment developed normally at all temperatures tested. Lowering the temperature to 18 °C substantially restored dAxin V72R's ability to prevent ectopic signaling (28%; n = 25 independent wing discs) (Fig. 6e) . dAxin L67P, similarly to moderately destabilized Axin L101P, was also temperature sensitive. This mutant fully rescued the loss of endogenous Axin at 25 °C but showed increased functional impairment at 29 °C (Fig. 6d) , consistently with our biophysical findings with the human homologs. We conclude that RGS destabilization induces tumor-like growth in vivo.
Suppressing aggregation restores mutant Axin function in vivo
As a stringent test of the hypothesis that blocking nanoaggregation rescues the activity of destabilizing RGS point mutants, we knocked in Axin RGS aggregon suppressor mutants at the endogenous locus. TANGO predicted only one clear aggregation-prone segment in dAxin (M167-I172), at a strikingly different location from that in human Axin (Fig. 5a,b) . We introduced antiaggregation mutations I169R L170R in this segment of dAxin V72R (Fig. 5b) . This exchange was sufficient to substantially restore Axin activity in wing discs in vivo (Fig. 6f and Supplementary Fig. 6d) . Moreover, whereas npg a r t i c l e s homozygous V72R mutant flies died at early developmental stages at all temperatures tested, the viability of homozygous V72R I169R L170R mutants was rescued up to the adult stage when flies were grown at 18 °C. Introduction of homologous mutations to the human aggregon suppressor mutant (Y86R F87R) did not restore activity (Supplementary Fig. 6e ). In line with these findings, the Drosophila but not the human aggregon suppressor mutation restored the ability of dAxin V72R to form cytosolic puncta in cells (Supplementary Fig. 7) .
Together, our findings demonstrate that it is not protein instability itself but subsequent protein nanoaggregation that causes tumor-like growth in vivo.
DISCUSSION
This study provides a molecular explanation of how cancer-associated missense mutations in the scaffold Axin lead to excess Wnt signaling. Our findings suggest that a subset of Axin point mutants drive tumorigenesis through a mechanism that is not merely caused by the loss of functional Axin. Instead, a single point mutation causes Axin to form soluble nanoaggregates that have tumorigenic activity in vivo. These oligomeric species lack typical characteristics of amyloids, such as fibrillar growth in vitro and SDS insolubility in vivo. Soluble oligomers are seen as major toxic agents in aggregation diseases, as described for Tau, α-synuclein and IAPP, by driving cellular degeneration and neuronal atrophy through a largely elusive mechanism 37,38 . In contrast, nanoaggregates of Axin are associated with tumorigenic growth in vivo. A comprehensive understanding of how their molecular mode of action causes a distinct phenotype is key to gaining a picture of the pathogenic mechanism of protein aggregation in general.
We propose the following model based on our findings ( Fig. 7) : Axin WT organizes the formation of a multiprotein complex by recruiting and directing the activity of partner proteins to suppress β-catenin-mediated transcription. In cancer cells, a single destabilizing point mutation endows the Axin protein with new properties, facilitating formation of an oligomeric core with disordered tentacles. The conformational conversion of Axin perturbs the associated interactome, thus resulting in both loss and gain of binding partners. When the mutant protein is in excess, the combined molecular events together trigger β-catenin signaling and drive tumorigenesis. Importantly, tumorigenic behavior of the mutant protein can be corrected by countering aggregation.
How do the aggregation properties of mutant Axin affect signaling? A multitude of proteins interact with Axin, clustering into three functionally distinct complexes 3 (Supplementary Fig. 5a ). A number of known partners operate together with Axin within the destruction complex, thereby regulating β-catenin turnover. Within this complex, proper timing and positioning of protein interactions is essential to coordinate and direct kinase activity and to allow for the capture and release of the β-catenin substrate protein for subsequent cycles of phosphorylation. In the case of the cancer mutant, nanoaggregation may aberrantly increase the spatial neighborhood of regulatory proteins that bind to the disordered tentacles of Axin. Consequently, the affinity of binding partners would be increased for entropic reasons, but undesired interactions between Axin binding partners might also be triggered. Together with the observed loss of binding of a number of Wnt-pathway regulators, these altered interactions may compromise the molecular activity of the destruction complex and aggravate the tumorigenic phenotype.
The Axin cancer-mutant interactome acquired a large number of new interactions (Supplementary Fig. 5e ). Gained partners were associated with the regulation of diverse cellular processes, including mitosis, DNA repair, protein trafficking and protein turnover. A fraction of these proteins may represent functional interaction partners that normally interact transiently with the disordered regions of Axin WT but are trapped by the tentacles of the aggregated conformation of the cancer mutant. Other gained partners may represent members of the proteostasis network that recognize misfolded or aggregated proteins. One example is the DNAJB6 protein, which binds only the aggregation-prone Axin mutant and has previously been described to interfere with the formation of larger polyglutamine peptide aggregates 39 . Another notable cluster of proteins that bind the cancer mutant comprises seven subunits of the 26S proteasome. Further insight into how the aggregated form but not the unfolded suppressor mutant of the protein is recognized and processed by the cellular proteostasis network is required to understand how the cancer mutant acquires a sufficient lifetime to perform its tumorigenic activity in the cell.
Aggregation is a conserved consequence of destabilizing mutations in both human and Drosophila Axin. Stability-sensitive regions are conserved between species. Unexpectedly, however, neither the sequence nor the location of the aggregon is conserved (Fig. 5) . Our work thus reveals that the positions of aggregons are not essential for the maintenance of protein folds and activity, and this phenomenon may constitute a general evolutionary principle.
The relevance of destabilizing point mutants has also been shown in other tumor suppressors, particularly for the DNA-binding domain of p53 (ref. 40) . In vivo, these mutants behave as dominant negatives, and some mutants gain new functions 41 . The mutants can induce large, amorphous aggregates that coaggregate WT p53 and its paralogs p63 and p73, thereby destroying their vital interaction with DNA and preventing their transcriptional activity 42 . Our findings suggest a different mode of action for Axin cancer mutants. First, the Axin mutant oligomers are small and soluble, and they comprise only a few molecules. Second, loss of function of the destabilized mutant domain is not responsible for the tumorigenic behavior of the Axin mutants. Third, Axin mutants do not operate as dominant-negative proteins, as shown by the normal development of heterozygous tissue in vivo and the normalization of assembly of mutant Axin complexes by Axin WT coexpression.
From our findings, we conclude that the nanoaggregational conformation of Axin cancer mutants mediates loss of binding and aberrantly Figure 7 Model for the mechanism of action of Axin RGS cancer variants. Axin WT forms a complex with partner proteins (blue ovals) and mediates tumor-suppressor activity. A single cancer point mutation endows Axin with new properties through formation of an oligomeric core with disordered tentacles. The altered conformation perturbs the associated subproteome (blue and red ovals) through both loss and gain of binding partners. The combined events drive Wnt-pathway activation and tumor growth. Tumorigenic behavior of the mutant protein is corrected by interference with aggregon-mediated oligomer formation. npg a r t i c l e s brings in critical binding partners while failing to properly coordinate their activity. The widespread effect of the mutant signaling hub thus derails the signaling circuitry in the cell, potentially affecting cellular processes such as cell division and energy metabolism. Given the overall similarity between the structural features of Axin and those of other tumor suppressors such as BRCA1 and APC, in which folded domains act in concert with large disordered segments, we propose that previously described cancer point mutations may operate through similar mechanisms 43, 44 . In this view, cancer mutants that destabilize scaffolds in cancer cells may deregulate multiple pathways by forming nanoaggregates that rewire signaling interactomes. We demonstrated that for reversion of the oncogenic gain-offunction phenotype it is sufficient to target the aggregon to prevent aggregation. It is not necessary to restore the damaged protein fold, which would be a much more complex goal. This finding opens up new avenues for cancer treatment by small molecules that address the problem of aggregation of the damaged scaffold.
METHODS
Methods and any associated references are available in the online version of the paper. Immunofluorescence and confocal microscopy. HEK293T cells were grown on glass coverslips in 24-well plates (coated with laminin). After overnight transfection of 30 ng of Axin per well, cells were either fixed in ice-cold methanol or in 4% paraformaldehyde (PFA) in 50 mM sodium phosphate, pH 7.4, buffer. After being quenched in 50 mM NH 4 Cl and blocked with 2% BSA and 0.1% saponin in PBS, cells were incubated with the primary antibody rabbit anti-V5 (Sigma, V8137) and then with the secondary antibody goat anti-rabbit Alexa568 (Molecular Probes, A11036). Cells were mounted in Prolong Gold with DAPI (Invitrogen, P36931). Images were acquired with a Zeiss LSM-510 confocal microscope and analyzed with ImageJ (http://imagej.nih.gov/ij/). The following antibodies were used: rabbit anti-V5 (Sigma, V8137), mouse anti-V5 (Genscript, A01724), rabbit anti-vimentin (Cell Signaling, 5741), rabbit anti-HDAC6 (Cell Signaling, 7558), mouse anti-γ-tubulin (Sigma, T5326), goat anti-rabbit Alexa568 (Molecular Probes, A11036), and goat anti-mouse Alexa488 (Molecular Probes, A11029). For all primary antibodies, validation is provided on the manufacturers' websites. CFTR-∆F508 aggresomes were induced as described previously 29 .
For wing imaginal discs, the following primary antibodies were used: guinea pig anti-Sens (a gift from H. Bellen, Baylor College of Medicine 49 ) and mouse anti-Dll (gift from I. Duncan and D. Duncan, Washington University 50 ). Alexaconjugated anti-guinea pig (Molecular Probes, A21435) or anti-mouse (Molecular Probes, A10037) were used as the secondary antibodies. Imaginal discs were mounted in Vectashield (Vector Laboratories), and Z stacks were acquired with a Leica SP5 confocal microscope. Projections along the Z axis were rebuilt starting from 35-55 Z stacks with ImageJ.
NMR spectroscopy. Samples for NMR measurements contained 0.1 mM protein in 20 mM sodium phosphate, pH 6.5, 150 mM NaCl and 1 mM DTT with 10% 2 H 2 O added for the lock signal. 1 H-15 N HSQC NMR spectra were recorded at 298 K on an Avance 600 Bruker NMR spectrometer equipped with a cryogenic triple-resonance gradient probe. All spectra were recorded with a recycle delay of 1.0 s, spectral widths of 20/30 p.p.m. centered at 4.7/118.5 p.p.m. in 1 H/ 15 N, with 1,024 and 128 points, respectively, and 64 scans per increment. Spectra were processed with NMRPipe/Draw and analyzed with Sparky 3 (http://www.cgl. ucsf.edu/home/sparky/). Residues in the intrinsically disordered region of RGS Axin-1 (residues 2-220) were tentatively assigned on the basis of a comparison of the recorded NMR spectra with NMR spectra published for an Axin-1 construct containing only the RGS domain (residues 88-211) 18 .
Small-angle X-ray scattering (SAXS) experiments. All experiments were carried out for purified proteins in 20 mM sodium phosphate, pH 6.5, 150 mM NaCl and 1 mM DTT at 298 K. SAXS data from solutions of WT, L101P and L106R Axin RGS domains were collected at the X33 beamline of the European Molecular Biology Laboratory (EMBL) Deutsches Elektronen Synchrotron (DESY) with a MAR345 image plate detector. Data were collected at 25 °C. The scattering patterns were measured with a 2-min exposure time (eight frames, each 15 s) for several solute concentrations in the range of 0.5 to 2.0 mg/ml. To assess radiation damage, the individual frames of the 2-min exposure were compared, and no changes were detected. With a sample-detector distance of 2.7 m, a range of momentum transfer of 0.01 < s < 0.6 Å −1 was covered (s = 4π sin(θ)/λ, where 2θ is the scattering angle, and λ = 1.5 Å is the X-ray wavelength). SAXS data of WT, L106R and L106R F119R Axin RGS were also recorded on an in-house SAXS instrument (SAXSess mc2, Anton Paar) equipped with a Kratky camera, a sealed X-ray-tube source and a two-dimensional Princeton Instruments PI·SCX:4300 CCD detector (Roper Scientific). The scattering patterns were measured with a 90-min exposure time (540 frames, each 10 s) for several solute concentrations in the range of 0.5 to 2 mg/ml. Radiation damage was excluded on the basis of a comparison of individual frames of the 90-min exposures, where no changes were detected. A range of momentum transfer of 0.012< s < 0.63 Å −1 was covered (s = 4π sin(θ)/λ, where 2θ is the scattering angle, and λ = 1.5 Å is the X-ray wavelength). All SAXS data were analyzed with standard techniques implemented in the package ATSAS and SAXSQuant (version 3.9, for in-house scattering data).
In-house scattering data were desmeared with GNOM and GIFT 51, 52 . The forward scattering, I(0), and the radius of gyration, R g , were evaluated with the Guinier approximation 53 , assuming that at very small angles (s <1.3/R g ), the intensity is represented as I(s) = I(0)exp((−s 2 R g 2 )/3). The values of I(0) and R g , as well as the maximum dimension, D max , and the interatomic distance distribution functions, (P(R)), were also computed with GNOM 52 . The scattering from the high-resolution models was computed with CRYSOL 54 . The masses of the solutes were evaluated by comparison of the forward scattering intensity with that from a bovine serum albumin reference solution (mass of 66 kDa).
Size-exclusion chromatography. SEC experiments of WT and mutant RGS were performed on a HiLoad Sepharose 16/600 pg75 column (GE Healthcare). Oligomer peaks were eluted at ~50-ml retention volume for RGS L106R and RGS L106R F119R (fractions eluting from 45.0 to 52.5 ml), and monomer peaks were eluted at ~58-ml retention volume of RGS WT and RGS L106R F119R (fractions eluting from 52.5 to 61.5 ml). The maximal concentration within the monomeric RGS peak was 20 µM.
Analytical ultracentrifugation. AUC sedimentation velocity experiments were performed on SEC oligomer peaks on a Beckman ProteomeLab XL-A analytical ultracentrifuge (Beckman) at RT. Sedimentation velocity experiments of WT, L106R and L106R F119R Axin RGS were performed for sample concentrations of 0.23 g/L in a buffer of 50 mM Tris, pH 8, 500 mM NaCl and 2 mM β-mercaptoethanol at 42,000 r.p.m. at 20 °C. The protein was detected by an absorbance optics system at a wavelength of 280 nm. Scans were recorded every 6 min. A monomer peak was observed at a sedimentation coefficient of 2 S, and oligomeric species ranged from 8 to 100 S. Larger aggregates may have formed because of the higher protein concentrations (>2 g/L) occurring during the sedimentation process. Data analysis to determine the contributions of different species was performed with the C(s)-analysis module of the UltraScan software package 55 . dc/dt plots for graphical comparison of different samples were generated with Sedview 56 .
Sample preparation for LC-MS/MS. Immunoprecipitated proteins on beads were resuspended in a spin filter column and washed three times with 200 µl of PBS to remove residual detergent from the lysis buffer. Bound proteins were then eluted off the beads first with 100 µl of 0.5% RapiGest SF (Waters) and then with 100 µl of 8 M urea, both dissolved in 50 mM ammonium bicarbonate, pH 8.0. Eluted proteins were reduced with 1 mM dithiothreitol (DTT) and alkylated with 5.5 mM iodoacetamide. For tryptic digestion, proteins were first digested with endoproteinase Lys-C (Wako Chemicals) at room temperature for 4 h; this was followed by digestion with sequencing-grade modified trypsin (Promega) overnight after four-fold dilution with 50 mM ammonium bicarbonate. Protease digestion was stopped by addition of trifluoroacetic acid (TFA) to a final concentration of 1%, and any precipitates were removed by centrifugation. Peptides were desalted with reversed-phase Sep-Pak C18 cartridges (Waters), dried and stored at −20 °C before LC-MS/MS.
Mass spectrometry. For LC-MS/MS analysis, peptides were first separated with a C18 column (Zorbax, Agilent) and introduced by nanoelectrospray into the LTQ Orbitrap Elite (Thermo Fisher) and MS/MS in data-dependent decision-tree mode (CID/ETD) as previously described 57 .
MS data analysis. Raw data files were analyzed with Proteome Discoverer (version 1.3). The top ten most intense MS2 peaks were selected within every 100-Da bin and searched against the UniProt Human database (version 2013-07; 20,277 entries) with the MASCOT search engine. Trypsin/P was chosen, cysteine carbamidomethylation was set as a fixed modification, and oxidation of methionine and acetylation of the N terminus were set as variable modifications. Peptide tolerance was set to 15 p.p.m., and MS/MS tolerance was set to 0.5 Da. All peptide-spectrum matches (PSMs) and proteins were validated with 1% FDR. Finally, to rank and score individual protein-protein interactions, we used workflow 3 from the CRAPome software (http://crapome.org/) 58 . The default settings were chosen for all analyses except for the following parameters of the SAINT probability score 59 , where we used n-burn = 2000; n-iter = 10,000; LowMode = 0; MinFold = 1 and Normalize = 1. To access changes in the interactome, each prey was assigned a probability score for interaction (SAINT score) ranging from npg
